We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.
Apr 21, 2017
Conatus Posters at EASL Meeting Address MELD Score Dynamics and Outcomes in Decompensated Liver Cirrhosis Patients, Including NASH Patients, Awaiting Liver Transplantation
Mar 27, 2017